Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible

Recent studies have demonstrated that erythropoietin (EPO) treatment in mice results in trabecular bone loss. Here, we investigated the dose-response relationship between EPO, hemoglobin (Hgb) and bone loss and examined the reversibility of EPO-induced damage. Increasing doses of EPO over two weeks...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolomansky, Albert, Hiram-Bab, Sahar, Ben-Califa, Nathalie, Liron, Tamar, Deshet-Unger, Naamit, Mittelman, Moshe, Oster, Howard S., Rauner, Martina, Wielockx, Ben, Neumann, Drorit, Gabet, Yankel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312352/
https://www.ncbi.nlm.nih.gov/pubmed/32471308
http://dx.doi.org/10.3390/ijms21113817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312352/
https://www.ncbi.nlm.nih.gov/pubmed/32471308
http://dx.doi.org/10.3390/ijms21113817

Ejemplares similares